OnKure Therapeutics (OKUR) Misses Q2 EPS by 114c

OnKure Therapeutics (NASDAQ: OKUR) reported Q2 EPS of ($1.14).

For earnings history and earnings-related data on OnKure Therapeutics (OKUR) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Barclays sees music streaming growth narrow gap with Spotify
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"